Lize F. D. van Vulpen

Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018

Shermarke Hassan, Rory C. Monahan, Evelien P. Mauser‐Bunschoten et al. · Journal of Thrombosis and Haemostasis · 2020 · 96 citations · Full text

Social Sciences, Hematology, Clinical Epidemiology +12

IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy

Lize F. D. van Vulpen, Roger E. G. Schutgens, K. Coeleveld et al. · Blood · 2015 · 85 citations · Full text

Medicine, Immunology, Pathobiology +14

Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study

Lize F. D. van Vulpen, M. E. R. van Meegeren, G. Roosendaal et al. · Osteoarthritis and Cartilage · 2014 · 70 citations

Medicine, Pathobiology, Pathology +17

Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study

Sarah J. Schep, Wobke E. M. van Dijk, Erik A.M. Beckers et al. · American Journal of Hematology · 2020 · 56 citations · Full text

Medicine, Hematology, Immunology +12

Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019

Shermarke Hassan, Erna C. van Balen, Cees Smit et al. · Journal of Thrombosis and Haemostasis · 2021 · 43 citations · Full text

Medicine, Health Policy, Hematology +14